Inozyme Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inozyme Pharma and other ETFs, options, and stocks.

About INZY

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.

CEO

Douglas A. Treco

CEODouglas A. Treco

Employees

Employees67

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2015

Founded2015

Employees

Employees67

INZY Key Statistics

Market cap

256.96M

Market cap256.96M

Price-Earnings ratio

-2.37

Price-Earnings ratio-2.37

Dividend yield

—

Dividend yield—

Average volume

7.24M

Average volume7.24M

High today

$3.99

High today$3.99

Low today

$3.94

Low today$3.94

Open price

$3.94

Open price$3.94

Volume

8.20M

Volume8.20M

52 Week high

$6.24

52 Week high$6.24

52 Week low

$0.721

52 Week low$0.721

Analyst ratings

88%

of 8 ratings

Buy

12.5%

Hold

87.5%

Sell

People also own

Based on the portfolios of people who own INZY. This list is generated using Robinhood data, and it’s not a recommendation.